Literature DB >> 15736755

Tricalcium-phosphate and hydroxyapatite bone-graft extender for use in impaction grafting revision surgery. An in vitro study on human femora.

E H van Haaren1, T H Smit, K Phipps, P I J M Wuisman, G Blunn, I C Heyligers.   

Abstract

Impacted morsellised allografts have been used successfully to address the problem of poor bone stock in revision surgery. However, there are concerns about the transmission of pathogens, the high cost and the shortage of supply of donor bone. Bone-graft extenders, such as tricalcium phosphate (TCP) and hydroxyapatite (HA), have been developed to minimise the use of donor bone. In a human cadaver model we have evaluated the surgical and mechanical feasibility of a TCP/HA bone-graft extender during impaction grafting revision surgery. A TCP/HA allograft mix increased the risk of producing a fissure in the femur during the impaction procedure, but provided a higher initial mechanical stability when compared with bone graft alone. The implications of the use of this type of graft extender in impaction grafting revision surgery are discussed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15736755     DOI: 10.1302/0301-620x.87b2.14749

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  13 in total

1.  Stability of fused versus nonfused THA femoral impaction grafts.

Authors:  Anneliese D Heiner; John J Callaghan; Thomas D Brown
Journal:  J Orthop Res       Date:  2007-03       Impact factor: 3.494

2.  Factors influencing the stability of stems fixed with impaction graft in vitro.

Authors:  Hirotsugu Ohashi; Masanori Matsuura; Tsuneyuki Ebara; Yusaku Okamoto; Hironori Kou
Journal:  Clin Orthop Relat Res       Date:  2009-01-29       Impact factor: 4.176

Review 3.  [Influence of thermodisinfection on impaction of cancellous bone : An in vitro model of femoral impaction bone grafting].

Authors:  C Fölsch; A Jahnke; A Groß; G Martels; G A Krombach; M Rickert; M Kampschulte
Journal:  Orthopade       Date:  2018-01       Impact factor: 1.087

4.  Electrospun PLGA and β-TCP (Rebossis-85) in a Lapine Posterolateral Fusion Model.

Authors:  J Christopher Nepola; Emily B Petersen; Nicole DeVries-Watson; Nicole Grosland; Douglas C Fredericks
Journal:  Iowa Orthop J       Date:  2019

5.  Influence of antibiotic pellets on pore size and shear stress resistance of impacted native and thermodisinfected cancellous bone: An in vitro femoral impaction bone grafting model.

Authors:  C Fölsch; J Bok; G A Krombach; M Rickert; C A Fonseca Ulloa; G A Ahmed; M Kampschulte; A Jahnke
Journal:  J Orthop       Date:  2020-09-19

6.  Novel osteoconductive β-tricalcium phosphate/poly(L-lactide-co-e-caprolactone) scaffold for bone regeneration: a study in a rabbit calvarial defect.

Authors:  Hanna Pihlman; Pauli Keränen; Kaarlo Paakinaho; Jere Linden; Markus Hannula; Iida-Kaisa Manninen; Jari Hyttinen; Mikko Manninen; Outi Laitinen-Vapaavuori
Journal:  J Mater Sci Mater Med       Date:  2018-10-08       Impact factor: 3.896

7.  Femoral revision with impaction bone grafting and a cemented polished tapered stem.

Authors:  I C Heyligers; B W Schreurs; E H van Haaren
Journal:  Oper Orthop Traumatol       Date:  2014-04-05       Impact factor: 1.154

8.  The effect of impaction and a bioceramic coating on bone ingrowth in porous titanium particles.

Authors:  Lucas H Walschot; Barend W Schreurs; Nico Verdonschot; Pieter Buma
Journal:  Acta Orthop       Date:  2011-04-19       Impact factor: 3.717

9.  Impaction bone grafting of the acetabulum at hip revision using a mix of bone chips and a biphasic porous ceramic bone graft substitute.

Authors:  Ashley W Blom; Vikki Wylde; Christine Livesey; Michael R Whitehouse; Steve Eastaugh-Waring; Gordon C Bannister; Ian D Learmonth
Journal:  Acta Orthop       Date:  2009-04       Impact factor: 3.717

10.  In vitro testing of femoral impaction grafting with porous titanium particles: a pilot study.

Authors:  René Aquarius; Luc Walschot; Pieter Buma; Berend Willem Schreurs; Nico Verdonschot
Journal:  Clin Orthop Relat Res       Date:  2009-01-13       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.